Global COPD and Asthma Devices Market Size
The Metered Dose Inhalers (MDIs) market dominated the Global COPD and Asthma Inhaler Market in 2015 and would continue till 2022 growing at a CAGR of 4.2 % during the forecast period. The Soft Mist Inhalers (SMIs) market is expected to reach a market size of $ 10,663.1 Million by 2022. The Dry Powder Inhalers (DPIs) market would witness the high growth rate of 7.4 % during 2016-2022.
The US market dominated the North America COPD and Asthma Metered Dose Inhalers (MDIs) Market in 2015 and would continue till 2022. The Canada market would witness the growth rate of 3.7% during 2016-2022.
The report highlights the adoption of COPD and Asthma Devices worldwide. Based on the product type; the market is segmented into Inhalers and Nebulizers market. Further the Inhaler segment is sub segmented into Dry Powder Inhalers, Metered Dose Inhalers and Soft Mist Inhalers Market. The Nebulizers segment is bifurcated into Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers Market. The geographies included in the report are North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa).
Key players profiled in the report include Glaxosmithcline PLC., Novartis International AG., Biotronik SE & Co. KG., AstraZeneca Plc., 3M Healthcare, GF Health Products, Inc., Sunovion Pharmaceuticals Inc., Smith Medicals, Inc., Baxter International and Philips.
Full report: https://kbvresearch.com/global-copd-and-asthma-devices-market/
The market is segmented based on product type and geography.
Global COPD and Asthma Devices, By Product Type
Global COPD and Asthma Devices Market
Global COPD and Asthma Inhaler Market
Global COPD and Asthma Dry Powder Inhalers (DPIs) Market
Global COPD and Asthma Metered Dose Inhalers (MDIs) Market
Global COPD and Asthma Soft Mist Inhalers (SMIs) Market
Global COPD and Asthma Nebulizer Market
Global COPD and Asthma Pneumatic Nebulizers Market
Global COPD and Asthma Ultrasonic Nebulizer Market
Global COPD and Asthma Mesh Nebulizer Market
Global COPD and Asthma Devices Market, By Geography
Rest of North America
Rest of Europe
Rest of Asia Pacific
Rest of LAMEA
North America COPD and Asthma Devices Market
Europe COPD and Asthma Devices Market
Asia Pacific COPD and Asthma Devices Market
LAMEA COPD and Asthma Devices Market
I am Kusum working with https://kbvresearch.com
as Digital Marketing Analyst,kbvreserach is an knowledge base value research organization.
which is a global brand and consulting firm serving all kinds of business verticals,
government and non-governmental organizations, and not-for-profit organizations.
Our motto is to extend our services that will have a lasting impact on our clients who trust us with their business goals.
244 Fifth Avenue, Suite 1407
New York, N.Y. 10001
United States (U.S)
Tel: +1 (646) 661-6066
Email : email@example.com
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global COPD and Asthma Devices Market Size here
News-ID: 649718 • Views: 388
More Releases from kbvresearch
Network Optimization Services Market
According to a new report Global Network Optimization Services Market, published by KBV research, the Global Network Optimization Services Market size is expected to reach $9.6 billion by 2023, rising at a market growth of 13.6% CAGR during the forecast period. The Professional market holds the largest market share in Global Network Optimization Services Market by Type in 2016, and would continue to be a dominant market till 2023. The Managed
Fleet Management Market Size
According to a new report Global Fleet Management Market, published by KBV research, the Global Fleet Management Market size is expected to reach $31.7 billion by 2023, rising at a market growth of 19% CAGR during the forecast period. The Asia Pacific market holds the largest market share in Global Asset Management Solution Market by Region in 2016, and would continue to be a dominant market till 2023; growing at a
Global Mobile Enterprise Application Market Size
According to a new report Global Mobile Enterprise Application market (2016-2022), published by KBV Research, the global Mobile Enterprise Application is expected to attain a market size of $105.7 billion by 2022, growing at a CAGR of 14.3% during the forecast period. Increase in smartphone market penetration, significant enhancement in connectivity & productivity of both employees and organizations, growing demand for capturing real-time information, and organizations’ continued focus for businesses to
Global User Provisioning Market Size
According to a new report Global User Provisioning Market, published by KBV research, the Global User Provisioning Market size is expected to reach $8.6 billion by 2023, rising at a market growth of 12% CAGR during the forecast period. The North America market holds the largest market share in Global Role Management Solution Market by Region in 2016, and would continue to be a dominant market till 2023; growing at a
More Releases for COPD
COPD Therapeutics Global Market Research Report 2019
COPD Therapeutics Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/copd-therapeutics-market/80858 The report firstly introduced the COPD Therapeutics basics: definitions, classifications, applications and market
Asthma and COPD Drugs Market worth $50,359 Million by 2022
"The key players of the Global COPD and asthma drugs market are employing novel concepts and ideas to improve, manage and control asthma & COPD, and also enhance their profitability so as to gain a competitive edge over the other market players. Seretide/Advair, Symbicort, and Singular were leading brands and accounted for around one-fourth share in world COPD and asthma drugs market." Global Asthma and COPD Drugs Market was valued at
Alarming Prevalence of COPD to Propel Oxygen Therapy Devices Market
"Oxygen therapy equipment market driven by increasing urbanization and rising levels of air pollution." An intelligence report on the global oxygen therapy equipment market has been added to the burgeoning portfolio of MarketResearchReports.biz. Titled, “Global Oxygen Therapy Equipment Market - Analysis By Product, Portability, Application, Region, Country: Opportunities and Forecast (2017- 2022) - By Product (Oxygen Concentrators, Liquid Oxygen Devices and Oxygen Cylinders), By Portability (Stationary, Portable Devices), By Application (COPD,
Asthma and COPD Drugs Market | Key Opportunities And Forecast 2024
The top five companies in the U.S. and China Asthma And Copd Drugs Market accounted for just under 64.0% in 2015, hinting at not just the consolidated nature of this industry but also at the immense competition among players. GlaxoSmithKline plc, Astrazeneca plc, Boehringer Ingelheim, Merck & Co. Inc., and Novartis AG currently enjoy the leading spots in the asthma and COPD drugs market. According to Transparency Market Research, the opportunity
COPD Drug Market Opportunity & Clinical Pipeline Analysis
Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the
Global COPD inhalers Industry:-Forecast 2022
Chronic Obstructive Pulmonary Disease (COPD) is a wide term used for progressive lung diseases which includes chronic bronchitis, emphysema, refractory asthma, and some forms of bronchiectasis. The symptoms of COPD includes recurrent coughing with or without sputum, difficulty in breathing, wheezing and tightness in the chest due to the blockage of lungs’ airways. More than 70 million people in the world are suffering from COPD as of 2015, majority of